
Important regulators of tumor growth, metastasis, and cellular regulation include Hyaluronan-mediated motility receptor (HMMR), Cadherin-1 (CDH1), Nucleoplasmin-1 (NPM1), and Histone deacetylase-5 (HDAC5). This study used bioinformatics technologies to examine their interrelationships and differential expression in gastric cancer. GEO2R was implemented to analyze DEGs from publicly available gastric cancer datasets. Venn analysis was then used to identify common DEGs, and heat-map visualization was used to evaluate expression patterns. Gastric cancer transcriptomic data were retrieved from the NCBI GEO database and analysed using GEO2R and Limma to identify DEGs. Visualization included volcano, box, and UMAP plots. Overlapping genes were assessed via BioVenn. Functional enrichment used GSEA, while immune infiltration was analysed through TIMER. Gene datasets for HMMR, CDH1, NPM1, and HDAC5 were retrieved from NCBI GEO and analysed for differential expression, revealing variable up- and downregulation across samples. Venn analysis showed minimal gene overlap. Enrichment analysis indicated significant expression patterns, particularly for HMMR and NPM1. Immune correlation revealed weak-to-moderate associations with CD8+ T cells. Mutation frequencies varied, with CDH1 highest (35%). sCNA and RNA-seq analyses demonstrated statistically significant alterations, supporting their potential roles in gastric cancer progression. Overall, the integrated bioinformatic approach showed different expression profiles of HMMR, CDH1, NPM1, and HDAC5 in gastric cancer. While altered expression of HMMR and HDAC5 highlights their potential contribution to cancer-related signaling and epigenetic regulation, NPM1 overexpression and CDH1 loss indicate opposing roles in tumor progression.
The widespread use of industrial chemicals has raised concerns about their potential to damage deoxyribonucleic acid (DNA), a process linked to cancer and other serious diseases. To explore this risk, we examined the genotoxic and cytotoxic effects of ethyl methane sulfonate (EMS), a known mutagen, in mice using the comet assay. Saline and corn oil served as vehicle controls. Body weight (BW) measurements showed no major differences between controls and treated groups over two days, although higher EMS doses were associated with slight reductions and greater variability, suggesting systemic stress. In contrast, DNA damage was strikingly dose-dependent. Duodenum, stomach, and liver tissues all showed significant increases in DNA strand breaks after EMS exposure, with duodenal cells in females appearing particularly sensitive. Cell viability declined progressively with increasing EMS doses across all tissues, while ghost cell frequency, a marker of cytotoxicity, rose in parallel. Importantly, vehicle controls remained stable, confirming that observed effects were due to EMS rather than solvents. Together, these findings demonstrate that EMS induces clear, dose-dependent DNA damage and cell stress in gastrointestinal and hepatic tissues. The comet assay proved to be a sensitive and reliable tool for detecting such genotoxic effects, reinforcing its value in toxicity testing. By highlighting tissue-specific and sex-related responses, this study underscores the importance of considering biological variability when assessing chemical hazards.
Maintenance of genomic integrity is essential for all organism that help to maintain the number of chromosomes during cell division. In yeast and other organisms, the diploidization of genome serves as a key survival strategy under changing environmental conditions. Fission yeast ATR homolog Rad3 and TOR complex protein Tor2 are phosphatidylinositol 3-kinase-related protein kinases (PIKKs) and are involved in various functions. Rad3 is a key regulator of DNA damage signaling pathway and is involved in the maintenance of genomic integrity. The TOR complex, TORC1 and TORC2, contain Tor2 and Tor1 protein kinase respectively as their major component are involved in regulating eukaryotic cell growth, metabolism, and survival, in response to nutrient, energy, and environmental cues. In this study, we observed the suppression of temperature sensitive phenotype of a tor2-287 mutation in rad3Δ background. The presence of azygotic asci and tetrad dissection analysis revealed the diploid nature of rad3Δ tor2-287 double mutant cells, which was further confirmed by flow cytometry (FACS) analysis. In addition, the tor2-287/tor2-287 homozygous and tor-287/tor2+ heterozygous diploid exhibit temperature sensitive and resistant phenotypes, respectively. The tetrad dissection analysis revealed that a wild type copy of the tor2+ and rad3+ genes was present in tor2-287 rad3Δ strain due to the diploid nature of these cells, thereby suppressing the temperature sensitive phenotype. Overall, our results demonstrate that the absence of rad3 suppresses the temperature sensitivity of tor2-287 mutant by maintaining the diploid nature of cells.
Background: The mutation of the KRAS proto-oncogene is frequently detected in various cancers, including hepatocellular carcinoma (HCC). This mutation often results in the failure of treatments based on tyrosine kinase receptor inhibitors. The study's objective was to investigate mutations of codon 12 and 13 of the KRAS gene and assess the risk of developing Hepatocellular Carcinoma. Methods: A prospective, cross-sectional, and analytical study was conducted from November 2018 to October 2021 at the biochemistry and molecular biology laboratory of Cheikh Anta Diop University’s Faculty of Medicine. Mutations of codons 12 and 13 were identified using High Resolution Melting and confirmed by sequencing. Hepatic assessments (transaminases, GGT, PAL, bilirubin, and AFP) were performed on all patients, and histopathological analysis was conducted. Results: The study consisted of 34 patients with an average age of 44±3.4 years and a sex ratio of 5.8. There was a predominance in the age group of 36 to 45 years (38.2%). The prevalence of the G12D mutation of the KRAS gene was 23.5% and was more common in subjects over 45 years (n=5; 11.7%). Hepatic impairments were less pronounced in carriers of the G12D mutation of the KRAS gene, albeit not significantly different. Additionally, tumors of grade 3 and type pT3 appeared more linked to the G12D mutation of the KRAS gene, with prevalences of 18.75% (n=3) and 30.8% (n=4), respectively. The relationship between chronic Hepatitis B Virus carriage and the KRAS gene mutation was not significant. Conclusion: Molecular biology significantly contributes to diagnosis and patient management by identifying molecular markers for pre-therapeutic evaluation.
Background: Cardiomyopathies are important causes of sudden cardiac death, and genetic variation contributes to their pathogenesis. AXIN1 encodes a scaffold protein that negatively regulates the Wnt/β-catenin pathway, which has essential roles in cardiac development and remodelling. The AXIN1 single-nucleotide polymorphism rs1805105 has been associated with susceptibility to dilated cardiomyopathy in a Chinese Han population, but evidence from medicolegal autopsy populations in Myanmar is lacking. Objective: To determine the distribution of AXIN1 rs1805105 genotypes and examine their association with types of fatal cardiomyopathy. Methods: A hospital-based cross-sectional descriptive study included 50 consecutives, histologically confirmed fatal cardiomyopathy cases received for medicolegal autopsy at Mandalay General Hospital from June 2020 to May 2021. Cardiomyopathy type was determined by gross and histopathological examination. DNA extracted from cardiac blood was genotyped for AXIN1 rs1805105 using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Descriptive statistics and Fisher’s exact test were used. Results: The mean age was 46.04 ± 13.11 years; 40 cases (80%) were male. Dilated cardiomyopathy (DCM) was identified in 38 cases (76%), hypertrophic cardiomyopathy (HCM) in 11 (22%), and restrictive cardiomyopathy (RCM) in one (2%). Genotype frequencies were CT in 25 cases (50%), TT in 16 (32%), and CC in nine (18%). Among DCM cases, CT was most frequent (21/38, 55.3%), followed by TT (10/38, 26.3%) and CC (7/38, 18.4%). Genotype distribution differed descriptively across cardiomyopathy types but was not statistically significant (Fisher’s exact p = 0.124). Genotype distribution was also not associated with sex (p = 0.809). Conclusion: AXIN1 rs1805105 variation was present in fatal cardiomyopathy cases, with the CT genotype predominating overall and in DCM. However, this small descriptive autopsy series did not demonstrate a statistically significant association between rs1805105 genotype and cardiomyopathy type. Larger case-control and multicentre studies evaluating additional variants are required.